• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纵向观察数据库中药物安全信号检测方法:LGPS 和 LEOPARD。

Methods for drug safety signal detection in longitudinal observational databases: LGPS and LEOPARD.

机构信息

Department of Medical Informatics, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.

出版信息

Pharmacoepidemiol Drug Saf. 2011 Mar;20(3):292-9. doi: 10.1002/pds.2051. Epub 2010 Oct 13.

DOI:10.1002/pds.2051
PMID:20945505
Abstract

PURPOSE

There is a growing interest in using longitudinal observational databases for drug safety signal detection, but most of the existing statistical methods are tailored towards spontaneous reporting. Here a sequential set of methods for detecting and filtering drug safety signals in longitudinal databases is presented.

METHOD

Longitudinal GPS (LGPS) is a modification of the Gamma Poisson Shrinker (GPS) that uses person time rather than case counts for the estimation of the expected number of events. Longitudinal Evaluation of Observational Profiles of Adverse events Related to Drugs (LEOPARD) is a method that can be used to automatically discard false drug-event associations caused by protopathic bias or misclassification of the dates of the adverse events by comparing prior event prescription rates to post event prescription rates. LEOPARD can generate a single test statistic, or a visualization that can be used for more qualitative information on the relationship between drug and event. Both methods were evaluated using data simulated using the Observational medical dataset SIMulator (OSIM), including the dataset used in the Observational Medical Outcomes Partnership (OMOP) cup, a recent public competition for signal detection methods. The Mean Average Precision (MAP) was used for performance measurement.

RESULTS

On the OMOP cup data, LGPS achieved a MAP of 0.245, and the combination of LGPS and LEOPARD achieved a MAP of 0.260, the highest score in the competition.

CONCLUSIONS

The sequential use of LGPS and LEOPARD have proven to be a useful novel set of methods for drug safety signal detection on longitudinal health records.

摘要

目的

使用纵向观察性数据库进行药物安全性信号检测的兴趣日益浓厚,但现有的大多数统计方法都是针对自发报告量身定制的。本文提出了一套用于在纵向数据库中检测和筛选药物安全性信号的顺序方法。

方法

纵向 GPS(LGPS)是 Gamma Poisson Shrinker(GPS)的一种改进,它使用人员时间而不是病例数来估计预期事件数。纵向评价与药物相关不良事件的观察性概况(LEOPARD)是一种可以通过将先前事件的处方率与事件后处方率进行比较,自动消除由前馈偏差或不良事件日期分类错误引起的虚假药物事件关联的方法。LEOPARD 可以生成单个检验统计量,或生成可视化结果,用于更定性地了解药物与事件之间的关系。这两种方法均使用使用 Observational medical dataset SIMulator(OSIM)模拟的数据进行了评估,包括最近公开的信号检测方法竞赛——Observational Medical Outcomes Partnership(OMOP)杯使用的数据。采用平均精度(MAP)进行性能评估。

结果

在 OMOP 杯数据中,LGPS 的 MAP 为 0.245,LGPS 和 LEOPARD 的组合的 MAP 为 0.260,在竞争中得分最高。

结论

在纵向健康记录中,使用 LGPS 和 LEOPARD 的顺序方法已被证明是一种有用的药物安全性信号检测新方法。

相似文献

1
Methods for drug safety signal detection in longitudinal observational databases: LGPS and LEOPARD.纵向观察数据库中药物安全信号检测方法:LGPS 和 LEOPARD。
Pharmacoepidemiol Drug Saf. 2011 Mar;20(3):292-9. doi: 10.1002/pds.2051. Epub 2010 Oct 13.
2
A potential competition bias in the detection of safety signals from spontaneous reporting databases.自发报告数据库中信号检测的潜在竞争偏倚。
Pharmacoepidemiol Drug Saf. 2010 Nov;19(11):1166-71. doi: 10.1002/pds.2022.
3
EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection.欧盟药品不良反应医疗保健数据库网络与自发报告系统数据库:信号检测的初步比较
Stud Health Technol Inform. 2011;166:25-30.
4
Adverse drug reactions in hospital and ambulatory care settings identified using a large administrative database.在医院和门诊护理环境中使用大型管理数据库识别药物不良反应。
Ann Pharmacother. 2010 Jun;44(6):983-93. doi: 10.1345/aph.1M726. Epub 2010 May 4.
5
The proportion of patient reports of suspected ADRs to signal detection in the Netherlands: case-control study.荷兰疑似不良反应报告占信号检测比例的病例对照研究。
Pharmacoepidemiol Drug Saf. 2011 Mar;20(3):286-91. doi: 10.1002/pds.2092. Epub 2010 Dec 28.
6
Signal detection in pharmacovigilance: empirical evaluation of data mining tools.药物警戒中的信号检测:数据挖掘工具的实证评估
Pharmacoepidemiol Drug Saf. 2005 Sep;14(9):597-9. doi: 10.1002/pds.1128.
7
Applying quantitative methods for detecting new drug safety signals in pharmacovigilance national database.应用定量方法在药物警戒国家数据库中检测新药安全信号。
Pharmacoepidemiol Drug Saf. 2007 Oct;16(10):1136-40. doi: 10.1002/pds.1459.
8
An evaluation of computer-aided disproportionality analysis for post-marketing signal detection.上市后信号检测的计算机辅助不成比例性分析评估。
Clin Pharmacol Ther. 2007 Aug;82(2):173-80. doi: 10.1038/sj.clpt.6100233. Epub 2007 May 16.
9
Likelihood ratio test-based method for signal detection in drug classes using FDA's AERS database.基于似然比检验的方法,利用美国食品药品监督管理局的不良事件报告系统数据库对药物类别中的信号进行检测。
J Biopharm Stat. 2013;23(1):178-200. doi: 10.1080/10543406.2013.736810.
10
Detection of adverse drug reaction signals using an electronic health records database: Comparison of the Laboratory Extreme Abnormality Ratio (CLEAR) algorithm.利用电子健康记录数据库检测药物不良反应信号:实验室极端异常比值(CLEAR)算法的比较。
Clin Pharmacol Ther. 2012 Mar;91(3):467-74. doi: 10.1038/clpt.2011.248. Epub 2012 Jan 11.

引用本文的文献

1
A discovery and verification approach to pharmacovigilance using electronic healthcare data.一种利用电子医疗数据进行药物警戒的发现与验证方法。
Front Pharmacol. 2024 Sep 4;15:1426323. doi: 10.3389/fphar.2024.1426323. eCollection 2024.
2
Optimal Significance Levels and Sample Sizes for Signal Detection Methods Based on Non-constant Hazards.基于非恒定风险的信号检测方法的最优显著水平和样本量。
Drug Saf. 2024 Nov;47(11):1149-1156. doi: 10.1007/s40264-024-01460-2. Epub 2024 Jul 9.
3
Enhancing antidepressant safety surveillance: comparative analysis of adverse drug reaction signals in spontaneous reporting and healthcare claims databases.
加强抗抑郁药安全性监测:自发报告和医疗保健理赔数据库中药物不良反应信号的比较分析
Front Pharmacol. 2024 Jan 8;14:1291934. doi: 10.3389/fphar.2023.1291934. eCollection 2023.
4
Methods for drug safety signal detection using routinely collected observational electronic health care data: A systematic review.利用常规收集的观察性电子医疗保健数据检测药物安全信号的方法:系统评价。
Pharmacoepidemiol Drug Saf. 2023 Jan;32(1):28-43. doi: 10.1002/pds.5548. Epub 2022 Nov 2.
5
Generalised weibull model-based approaches to detect non-constant hazard to signal adverse drug reactions in longitudinal data.基于广义威布尔模型的方法,用于在纵向数据中检测非恒定风险以提示药物不良反应。
Front Pharmacol. 2022 Aug 23;13:889088. doi: 10.3389/fphar.2022.889088. eCollection 2022.
6
Challenges and Opportunities of Real-World Data: Statistical Analysis Plan for the Optimise:MS Multicenter Prospective Cohort Pharmacovigilance Study.真实世界数据的挑战与机遇:Optimise:MS多中心前瞻性队列药物警戒研究的统计分析计划
Front Neurol. 2022 Mar 28;13:799531. doi: 10.3389/fneur.2022.799531. eCollection 2022.
7
OPTIMISE: MS study protocol: a pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosis.OPTIMISE:MS 研究方案:一项实用的、前瞻性的观察性研究,旨在解决多发性硬化症真实世界药物警戒的需求和挑战。
BMJ Open. 2021 Nov 25;11(11):e050176. doi: 10.1136/bmjopen-2021-050176.
8
How Confident Are We about Observational Findings in Healthcare: A Benchmark Study.我们对医疗保健领域观察性研究结果的信心有多少:一项基准研究。
Harv Data Sci Rev. 2020;2(1). doi: 10.1162/99608f92.147cc28e. Epub 2020 Jan 31.
9
Signal Detection of Potentially Drug-Induced Liver Injury in Children Using Electronic Health Records.利用电子健康记录对儿童潜在药物性肝损伤进行信号检测
Front Pediatr. 2020 Apr 16;8:171. doi: 10.3389/fped.2020.00171. eCollection 2020.
10
Hypothesis-free signal detection in healthcare databases: finding its value for pharmacovigilance.医疗保健数据库中的无假设信号检测:探寻其在药物警戒中的价值。
Ther Adv Drug Saf. 2019 Aug 5;10:2042098619864744. doi: 10.1177/2042098619864744. eCollection 2019.